Given the low incidence rate of Burkitt lymphoma (BL) (27), which poses challenges for building clinical prediction models requiring large sample sizes, and considering that DLBCL shares key clinical features with BL—such as high proliferative and invasive characteristics—while exhibiting a higher prevalence (28), we selected DLBCL for molecular clustering analysis based on ERG expression. The gene discussed is ERG; the disease is Burkitt lymphoma.